Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization

scientific article (publication date: October 2013)

Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CGH.2013.04.028
P3181OpenCitations bibliographic resource ID2421007
P698PubMed publication ID23644386

P50authorRiad SalemQ45736667
Zeeshan ButtQ57072378
David CellaQ62568473
P2093author name stringLaura Kulik
Daniel Ganger
Ahsun Riaz
Talia Baker
Khairuddin Memon
Michael Vouche
Rohi Atassi
Ryan Hickey
Robert Lewandowski
Michael M. Abecassis
Al B. Benson
James L. Burns
Margaret Gilbertsen
Mary F. Mulcahy
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectquality of lifeQ13100823
hepatocellular carcinomaQ1148337
P304page(s)1358-1365.e1
P577publication date2013-10-01
P1433published inClinical Gastroenterology and HepatologyQ5133759
P1476titleIncreased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization
P478volume11

Reverse relations

cites work (P2860)
Q38465831(90)Y-glass microspheres for hepatic neoplasia
Q59783545Association of PI3K Pathway Mutations with Early Positron-Emission Tomography/CT Imaging Response after Radioembolization for Breast Cancer Liver Metastases: Results of a Single-Center Retrospective Pilot Study
Q26744307Current status of transarterial radioembolization
Q98289959Epidemiologic, humanistic and economic burden of hepatocellular carcinoma in the USA: a systematic literature review
Q41108851FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib.
Q57756376Hepatocellular carcinoma
Q61804598History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma
Q38283692How does selective internal radiation therapy compare with and/or complement other liver-directed therapies
Q38984450In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization?
Q47573685Incorporating Quality of Life Metrics in Interventional Oncology Practice
Q47384456Institutional Decision to Adopt Y90 as Primary Treatment for HCC Informed by a 1,000-patient 15-year Experience.
Q38149993Intraarterial therapies for primary liver cancer: state of the art.
Q94951977Liver Transplantation Following Yttrium-90 Radioembolization: 15-year Experience in 207-Patient Cohort
Q49627939Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Q38686790Locoregional and systemic therapy for hepatocellular carcinoma
Q87664325Management of hepatocellular carcinoma
Q53216812Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus 90Y-radioembolization for hepatocellular carcinoma.
Q38904263New concepts in embolotherapy of HCC.
Q35128190Outcome of transarterial chemoembolization-based multi-modal treatment in patients with unresectable hepatocellular carcinoma
Q37611108Patient-reported outcomes in liver transplant recipients with hepatocellular carcinoma
Q48058236Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma
Q90746927Position 2: Transarterial Radioembolization Should Be the Primary Locoregional Therapy for Unresectable Hepatocellular Carcinoma
Q48049674Preservation of quality of life with doxorubicin drug-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: Longitudinal prospective study
Q47556433Prospective longitudinal quality of life and survival outcomes in patients with advanced infiltrative hepatocellular carcinoma and portal vein thrombosis treated with Yttrium-90 radioembolization
Q26753024Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
Q90214924Quality of life in patients undergoing repetitive TACE for the treatment of intermediate stage HCC
Q33872976Radioembolization for the treatment of hepatocellular carcinoma
Q93377794Radioembolization versus chemoembolization for unresectable hepatocellular carcinoma: a meta-analysis of randomized trials
Q36062588Radioembolization with Yttrium-90 microspheres for patients with unresectable hepatocellular carcinoma
Q27023616Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectives
Q35164855Randomized comparison of selective internal radiotherapy (SIRT) versus drug-eluting bead transarterial chemoembolization (DEB-TACE) for the treatment of hepatocellular carcinoma.
Q42378410Reactive oxygen species dependent phosphorylation of the liver kinase B1/AMP activated protein kinase/ acetyl-CoA carboxylase signaling is critically involved in apoptotic effect of lambertianic acid in hepatocellular carcinoma cells
Q34045215Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial.
Q27007847Systematic review of catheter-based intra-arterial therapies in hepatocellular carcinoma: state of the art and future directions
Q32173610Systematic review of patient reported quality of life following stereotactic ablative radiotherapy for primary and metastatic liver cancer.
Q26753089Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
Q38488732Transarterial approaches to primary and secondary hepatic malignancies.
Q34702094Transarterial embolization therapies for the treatment of hepatocellular carcinoma: CEPO review and clinical recommendations
Q26852174Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments
Q33935237Transcatheter arterial chemoembolization for intermediate-stage hepatocellular carcinoma: clinical outcome and safety in elderly patients
Q95282127Trial Design and Endpoints in hepatocellular carcinoma: AASLD Consensus Conference
Q30248206Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis.
Q38626594Value of quality of life analysis in liver cancer: A clinician's perspective
Q36268905Yttrium-90 Radioembolization of Hepatocellular Carcinoma-Performance, Technical Advances, and Future Concepts
Q26743603Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review
Q35631304Yttrium-90 microsphere radioembolization for hepatocellular carcinoma
Q36482781Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy.
Q58804965Yttrium-90 transarterial radioembolization versus conventional transarterial chemoembolization for patients with hepatocellular carcinoma: a systematic review and meta-analysis

Search more.